313 related articles for article (PubMed ID: 17964409)
1. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
Moshirfar M; Meyer JJ; Espandar L
J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
[TBL] [Abstract][Full Text] [Related]
2. Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy.
de la Cruz J; Behlau I; Pineda R
J Cataract Refract Surg; 2007 Jul; 33(7):1318-21. PubMed ID: 17586393
[TBL] [Abstract][Full Text] [Related]
3. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
Moshirfar M; Mirzaian G; Feiz V; Kang PC
J Cataract Refract Surg; 2006 Mar; 32(3):515-8. PubMed ID: 16631067
[TBL] [Abstract][Full Text] [Related]
4. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR
Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641
[TBL] [Abstract][Full Text] [Related]
5. The increasing problem of antibiotic resistance.
Mamalis N
J Cataract Refract Surg; 2007 Nov; 33(11):1831-2. PubMed ID: 17964369
[No Abstract] [Full Text] [Related]
6. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
[TBL] [Abstract][Full Text] [Related]
8. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone.
Hamam RN; Noureddin B; Salti HI; Haddad R; Khoury JM
Ophthalmology; 2006 Jun; 113(6):950-4. PubMed ID: 16647126
[TBL] [Abstract][Full Text] [Related]
9. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
[TBL] [Abstract][Full Text] [Related]
10. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
Shih MH; Huang FC
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil.
Höfling-Lima AL; de Freitas D; Sampaio JL; Leão SC; Contarini P
Cornea; 2005 Aug; 24(6):730-4. PubMed ID: 16015094
[TBL] [Abstract][Full Text] [Related]
12. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
Abshire R; Cockrum P; Crider J; Schlech B
Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium chelonae wound ulcer after clear-cornea cataract surgery.
Mah-Sadorra JH; Cohen EJ; Rapuano CJ
Arch Ophthalmol; 2004 Dec; 122(12):1888-9. PubMed ID: 15596600
[No Abstract] [Full Text] [Related]
14. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
[TBL] [Abstract][Full Text] [Related]
15. Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.
Pacheco PA; Tam PM
J Cataract Refract Surg; 2010 May; 36(5):843-6. PubMed ID: 20457379
[TBL] [Abstract][Full Text] [Related]
16. Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Daines BS; Vroman DT; Sandoval HP; Steed LL; Solomon KD
J Cataract Refract Surg; 2003 May; 29(5):1014-8. PubMed ID: 12781292
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
Sarayba MA; Shamie N; Reiser BJ; Sweet PM; Taban M; Graff JM; Kesler-Diaz A; Osann KE; McDonnell PJ
J Cataract Refract Surg; 2005 Jul; 31(7):1396-402. PubMed ID: 16105613
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis.
Giaconi J; Pham R; Ta CN
J Cataract Refract Surg; 2002 May; 28(5):887-90. PubMed ID: 11978473
[TBL] [Abstract][Full Text] [Related]
19. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
Jhanji V; Sharma N; Satpathy G; Titiyal J
J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
[TBL] [Abstract][Full Text] [Related]
20. Topical linezolid for refractory bilateral Mycobacterium chelonae post-laser-assisted in situ keratomileusis keratitis.
Dolz-Marco R; Udaondo P; Gallego-Pinazo R; Millán JM; Díaz-Llopis M
Arch Ophthalmol; 2012 Nov; 130(11):1475-6. PubMed ID: 23143454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
